THE Dry Lab^TM is a pioneering multi-omics Life Science research platform targeting cancers, metabolic disorders and neurodegenerative disorders, that integrates Molecular, Stem Cells, Bioinformatics, Machine Learning and Artificial Intelligence to deliver actionable outcomes of products and rapid commercialisation. THE Dry Lab^TM combines Systems Biology, WGS, Big Data analysis and product development capabilities.

THE Dry Lab^TM is a state-of-the-art life sciences facility that combines product development capabilities with directed research services. THE Dry Lab^TM is aimed at driving wider practical outcomes and commercialisation of AGENOME’s research programmes.

Key Drivers of THE Dry Lab^TM

• Systems Biology analyses of The Avestagenome Project® samples which include Liquid Biopsies (cfDNA, cfRNA)
• Genomics laboratory for Whole Genome Sequencing of Zoroastrian Parsi genomes
• Big Data Analysis to analyze and integrate data from genomics, transcriptomics, proteomics and metabolomics.
• Informed consent from the Zoroastrian Parsi and extended Indian population sample BIOBANK and database offers repeated collections, insights and comparative study opportunities across cancers and diverse disease states – a living cohort offering cradle to grave data analyses of the incidence and characterisation of cancers and disease states over the individual’s lifetime as part of a large and statistically relevant control population

Key Deliverables of THE Dry Lab^TM

• To elucidate gene function to identify new genes that predisposes individuals to a range of diseases
• To identify regions of interest and qualified biomarkers leading to predictive diagnostic tests
• To identify which experimental drugs will be most likely to succeed from generated data
• To conserve the biological heritage of the endogamous Zoroastrian Parsi population
• To create disease-specific family-based pluripotent stem cell lines
• To benefit the Parsi community by identifying the causal genes and other factors causing the diseases prevalent in the community
• To use “insights and products” derived from the Parsi community to drive similar benefits for other similar communities in tackling inherent diseases with predictive diagnostics and drugs globally
• To provide a pipeline of diagnostic / pharma products for in-house and out-licensed development and commercialisation

Our mission is to harness the strengths of our PPP – Preventive, Predictive and Personalized platform to advance research in the OMICS, molecular and stem cell technology in synergy with data mining and AI/ML platforms to drive the creation of proprietary technology in Precision Medicine, Agriculture and Nutrigenomics. THE Dry lab™ encourages and facilitates partnerships and co-development with relevant players in the life sciences industry and global research community.